{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:10:17Z","timestamp":1784182217691,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoinflammation with Infantile Enterocolitis (AIFEC, OMIM#616050) is a rare autosomal dominant autoinflammatory disorder caused by gain-of-function mutations in the NLRC4 gene. The disease is characterized by recurrent systemic inflammatory flares with enterocolitis as a hallmark feature, though clinical presentations are broad and often nonspecific.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      This report describes a noteworthy case of a pediatric patient with rare NLRC4 gene mutation leading to AIFEC. The patient was a 2-year-and-4-month-old female who presented with recurrent fever, chronic diarrhea, mucous bloody stools, and multi-system involvement. She had a history of multiple infections since early childhood. Laboratory investigations indicated significantly elevated inflammatory markers and endoscopic examination revealed multiple ulcers in the ileocolonic region. Whole-exome sequencing identified a\n                      <jats:italic>de novo<\/jats:italic>\n                      heterozygous mutation c.167A\u2009&amp;gt;\u2009G (p.His56Arg) in the CARD domain of NLRC4 gene, which was validated by Sanger sequencing and functionally assessed for pathogenicity. This specific gene locus mutation has not been reported in domestic or international literature to date. Clinical remission was achieved following infliximab treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case identifies a novel NLRC4 variant (c.167A\u2009&amp;gt;\u2009G, p.His56Arg) located in the CARD domain. Our findings expand the known mutational and phenotypic spectrum of AIFEC and add to emerging clinical evidence suggesting the potential utility of infliximab as a targeted therapeutic option for this rare autoinflammatory condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1878056","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:40:16Z","timestamp":1784180416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoinflammation with infantile enterocolitis associated with a novel CARD domain mutation in NLRC4: a case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Yifan","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Pediatric Gastroenterology, West China Second University Hospital of Sichuan University, Chengdu, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University","place":["Chengdu, China"]},{"name":"West China College of Clinical Medicine, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, West China Second University Hospital of Sichuan University, Chengdu, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s42003-026-10174-3","article-title":"Current understanding of the NLRC4 inflammasome in autoinflammation and enterocolitis","volume":"9","author":"Wang","year":"2026","journal-title":"Commun Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102298","DOI":"10.1016\/j.mib.2023.102298","article-title":"Human and mouse NAIP\/NLRC4 inflammasome responses to bacterial infection","volume":"73","author":"Egan","year":"2023","journal-title":"Curr OpinMicrobiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41577-024-00995-w","article-title":"Mechanistic insights from inflammasome structures","volume":"24","author":"Fu","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12969-024-01020-z","article-title":"Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)","volume":"22","author":"Asna Ashari","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3760\/cma.j.cn113903-20220520-00512","article-title":"A case of neonatal-onset autoinflammation with infantile enterocolitis caused bya de novo NLRC4 gene variation[J]","volume":"25","author":"Cheng","year":"2022","journal-title":"Chinese Journal of Perinatal Medicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3389\/fimmu.2018.02162","article-title":"Rapamycin as an adjunctive therapy for NLRC4 associated macrophage activation syndrome","volume":"9","author":"Barsalou","year":"2018","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10875-019-00611-w","article-title":"Autoinflammation with infantile enterocolitis associated with recurrent perianal abscesses","volume":"39","author":"Siahanidou","year":"2019","journal-title":"J Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammationsuccessfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1822554","DOI":"10.3389\/fped.2026.1822554","article-title":"Autoinflammation with infantile enterocolitis induced by a heterozygous variant (c.1357C>T) in the NLRC4 gene: a case report","volume":"14","author":"Wang","year":"2026","journal-title":"Front Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"O68","DOI":"10.1186\/1546-0096-13-S1-O68","article-title":"Anti interferon-gamma (IFN\u03b3) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis","volume":"13","author":"Bracaglia","year":"2015","journal-title":"Pediatric Rheumatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jaci.2023.03.031","article-title":"Microbiota transplant to control inflammation in a patient with NLRC4 gain-of-function-induced disease","volume":"152","author":"Bracaglia","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.41999","article-title":"First description of late-onset autoinflammatory disease due to somatic NLRC4 mosaicism","volume":"74","author":"Ionescu","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41423-025-01355-x","article-title":"An animal model of NLRC4-associated autoinflammation and infantile enterocolitis reveals novel therapeutic strategies","volume":"22","author":"Wang","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/imr.12607","article-title":"The NLRC4 inflammasome","volume":"281","author":"Duncan","year":"2018","journal-title":"Immunol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.it.2025.03.008","article-title":"Inflammasomopathies: mechanisms and disease signatures","volume":"46","author":"Cahill","year":"2025","journal-title":"TrendsImmunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0066321","DOI":"10.1128\/iai.00663-21","article-title":"Salmonella enterica serovar Typhimurium induces NAIP\/NLRC4- and NLRP3\/ASC-independent, caspase-4-dependent inflammasome activation in human intestinal epithelial cells","volume":"90","author":"Naseer","year":"2022","journal-title":"Infect Immun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105903","DOI":"10.1016\/j.jbspin.2025.105903","article-title":"Dysregulation of inflammasomes in autoinflammatory diseases","volume":"92","author":"Hou","year":"2025","journal-title":"Joint Bone Spine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"951535","DOI":"10.3389\/fimmu.2022.951535","article-title":"Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases","volume":"13","author":"Shimizu","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/ijo.2024.5687","article-title":"NLRC4, Inflammation and colorectal cancer (review)","volume":"65","author":"Tong","year":"2024","journal-title":"Int J Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3748\/wjg.v29.i18.2733","article-title":"Study of tumor necrosis factor receptor in the inflammatory bowel disease","volume":"29","author":"Souza","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12967-024-05058-1","article-title":"Predictive biomarkers for anti-TNF alpha therapy in IBD patients","volume":"22","author":"Kumar","year":"2024","journal-title":"J Transl Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2468-1253(21)00312-5","article-title":"Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's Disease: a systematic review and network meta-analysis","volume":"6","author":"Singh","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/jpn3.70267","article-title":"Subcutaneous infliximab use in children with inflammatory bowel disease in an Australian center","volume":"82","author":"Eldredge","year":"2026","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1878056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:40:17Z","timestamp":1784180417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1878056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":28,"alternative-id":["10.3389\/fped.2026.1878056"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1878056","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1878056"}}